Impax Case Dies With Endo Pay-For-Delay Suit, FTC Says
The Federal Trade Commission's dismissal of a pay-for-delay suit against Endo Pharmaceuticals Inc. over pain drugs Opana ER and Lidoderm should apply to Impax Laboratories Inc. too, which was terminated from...To view the full article, register now.
Already a subscriber? Click here to view full article